LifeSci Advisors in collaboration with Westmount Capital are bringing for the third to Milano Protalix Biotherapeutics, a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare diseases
LifeSci Advisors in collaboration with Westmount Capital are pleased to bring to Milano for the third time Protalix Biotherapeutics, a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare diseases. We are advancing promising candidates leveraging our expertise in protein therapeutics through our proprietary, commercial-scale ProCellEx® plant cell-based protein expression system, as…